| 
			
			 U.S. investors appear less concerned with whether Republicans take 
			control of the Senate, as expected, or Democrats hang on to their 
			majority by a slim margin. They just want to know - come Wednesday 
			morning - the actual outcome. 
 "If we have a really uncertain situation, where the Senate is 
			divided and candidates are threatening recounts, that's really not 
			good," said Robbert van Batenburg, director of market strategy at 
			Newedge USA LLC in New York.
 
 In two southern matchups - Louisiana and Georgia - polls show the 
			races are too tight to call, raising the potential for run-off 
			elections that could delay for weeks knowing who will control 
			Congress' upper chamber. Louisiana's run-off election is scheduled 
			for Dec. 6. In the market's worst-case scenario, the majority party 
			may not be known until after Jan. 6, when Georgia will hold its 
			run-off election if no Senate candidate wins at least 50 percent of 
			the vote on Nov. 4.
 
 Such an outcome, while considered unlikely, nevertheless rekindles 
			uncomfortable memories for some of the 2000 presidential election, 
			when George W. Bush's victory over Al Gore was not confirmed for 
			more than a month after Election Day. That uncertainty contributed 
			to a spike of almost 11.2 percent in the CBOE Volatility index 
			<.VIX> and a 7.6 percent drop in the S&P 500 <.SPX> from Election 
			Day through the Electoral College vote in late December that 
			certified the outcome.
 
			
			 
			"While the reaction wouldn't be that dramatic this time, any form of 
			risk could really jolt equities, especially since the Federal 
			Reserve is no longer in the market," van Batenburg said, referring 
			to the U.S. central bank's decision last week to end its massive 
			bond-buying program, a stimulus measure which has been credited with 
			boosting equities.
 CLARITY COULD ADD LEGS TO REBOUND
 
 U.S. stocks have roared back in the past two weeks after an early 
			October scare fest. The S&P is up more than 8 percent since its 
			recent closing low on Oct. 15 and the VIX has tumbled some 45 
			percent.
 
 A clear outcome on Tuesday, then, could set the market up for 
			additional upside into the end of the year.
 
 Historically, midterm elections correspond with market strength. 
			Barclays noted that since 1928, the S&P 500 has posted a median 
			return of 7 percent in the 90 days after a midterm, with returns 
			positive 86 percent of the time.
 
 Upside in mid-term election years has historically favored 
			small-caps. Since 1990, the Russell 2000 <.TOY> has risen an average 
			of 4.89 percent between Election Day and the end of the year, 
			compared with a rise of 3.22 percent in the S&P over the same period 
			and a rise of 2.28 percent in the Dow.
 
 [to top of second column]
 | 
            
 
			Those gains are close to the averages for all years, with the 
			Russell 2000 rising 4.6 percent in the last two months of the year 
			and the S&P up 3.2 percent in the last two months, according to the 
			Stock Trader's Almanac.
 CONTROLLING PARTY
 
 Barclays Capital estimates a 64 to 90 percent chance that 
			Republicans would win the Senate. With neither party likely to 
			achieve a large enough majority to overturn vetoes or prevent 
			filibusters, however, the actual party in power may not matter much 
			on Wall Street.
 
 A "new composition is unlikely to enact changes in the near term 
			that will alter the direction of the equity market," Barclays wrote. 
			"If the election results are a surprise and Democrats keep control 
			of the Senate, we believe the market reaction would still be muted."
 
 There could be outsized moves in the energy and medical device 
			sectors, two groups with ties to Republican-driven legislation. The 
			GOP is generally opposed to the Affordable Care Act's imposition of 
			a tax on medical device companies to fund the healthcare program, 
			and the party is widely in support of the Keystone Pipeline project, 
			which would connect Canadian oil sands with U.S. refineries.
 
 "If the majority party of the Senate is in doubt, that would cause a 
			lot of volatility for medical device names like Stryker <SYK.N> and 
			Medtronic <MDT.N>, most likely with a downward bias," said Michael 
			Mullaney, chief investment officer at Fiduciary Trust Co in Boston.
 
 (Reporting by Ryan Vlastelica; Editing by Leslie Adler)
 
			[© 2014 Thomson Reuters. All rights 
				reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			 |